hCAP-D3 Inhibitors
hCAP-D3 inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the hCAP-D3 protein, also known as Condensin II complex subunit D3. hCAP-D3 is a crucial component of the Condensin II complex, which is responsible for the organization and condensation of chromatin during various cellular processes, including cell division, DNA repair, and gene regulation. The Condensin II complex helps package long stretches of DNA into highly compacted structures, such as chromosomes, ensuring their proper segregation during cell division and facilitating efficient access to genetic information. hCAP-D3, as part of this complex, plays a central role in mediating chromatin condensation and chromosome dynamics, making it essential for maintaining genomic stability and regulating gene expression. Inhibitors developed to target hCAP-D3 are primarily employed in molecular and cellular biology research to investigate the functional properties and regulatory mechanisms associated with this protein.
The development of hCAP-D3 inhibitors typically involves a combination of biochemical, biophysical, and structural approaches aimed at identifying or designing molecules that can selectively interact with hCAP-D3 and modulate its activity within the Condensin II complex. By inhibiting hCAP-D3, these compounds can potentially disrupt the proper condensation of chromatin, leading to aberrant chromosome structure and potential defects in crucial cellular processes like mitosis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that changes chromatin structure and gene expression, potentially affecting hCAP-D3 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that can cause hypomethylation of DNA and alter gene expression, possibly affecting hCAP-D3 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Similar to 5-azacytidine, it may cause DNA hypomethylation and could alter the expression of genes like hCAP-D3. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor that may lead to cell cycle arrest and indirectly affect hCAP-D3 expression. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
A cytidine analog that inhibits DNA methylation and could potentially alter gene expression, including hCAP-D3. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor that can affect chromatin structure and gene expression, which may include hCAP-D3. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Another histone deacetylase inhibitor that can have broad effects on gene expression, potentially altering hCAP-D3 levels. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
A histone deacetylase inhibitor that may change the expression of numerous genes, including possibly hCAP-D3. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Acts as a histone deacetylase inhibitor and could influence the expression pattern of genes like hCAP-D3. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
A PARP inhibitor, which by influencing DNA repair processes, might have downstream effects on hCAP-D3 expression. | ||||||